NCT03944811

Bone Height Gain Following Transcrestal Sinus Floor Elevation Using Piezoelectric Surgery Versus The Conventional Osteotome Technique

Completed NA Last updated 5 November 2021

What this trial tests

NA trial testing piezoelectric device in Alveolar Bone Loss in 24 participants. Completed in 1 April 2021.

Timeline

1 September 2019

Primary endpoint
22 January 2021

1 April 2021

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	24
Start date	1 September 2019
Primary completion	22 January 2021
Estimated completion	1 April 2021
Sites	1 location across Egypt

Drugs / interventions tested

• piezoelectric device
• Summers technique

Conditions studied

• Alveolar Bone Loss — all drugs for Alveolar Bone Loss →

Sponsor

Cairo University

Who can join

Adults 20 to 60, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Missing teeth usually result in functional and cosmetic deficits. Traditionally, they have been restored with dentures or fixed bridges. However, dental implants represent an excellent alternative which rely on the maintenance of a direct structural and functional connection between living bone and implant surface, which is termed osseointergration. When sufficient bone is available in maxilla, implant rehabilitation has shown high success rates of 84-92 %. Atrophy of the alveolar crest and pneumatization of the maxillary sinus limits the quality and quantity of residual bone, therefore complicating the placement of implants in the posterior maxillary area.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.